Journal Article

Clinical and translational implications of immunotherapy in sarcomas

Miserocchi, Giacomo, Liverani, Chiara, Casadei, Roberto, Diano, Danila, Recine, Federica, Pieri, Federica, Mercatali, Laura, De Vita, Alessandro, Bongiovanni, Alberto, Fausti, Valentina, Ibrahim, Toni, Vanni, Silvia, Falbo, Pina Tiziana, Cavaliere, Davide

2024

Overview

Immunotherapy has emerged as promising treatment in sarcomas, but the high variability in terms of histology, clinical behavior and response to treatments determines a particular challenge for its role in these neoplasms. Tumor immune microenvironment (TiME) of sarcomas reflects the heterogeneity of these tumors originating from mesenchymal cells and encompassing more than 100 histologies. Advances in the understanding of the complexity of TiME have led to an improvement of the immunotherapeutic responsiveness in sarcomas, that at first showed disappointing results. The proposed immune-classification of sarcomas based on the interaction between immune cell populations and tumor cells showed to have a prognostic and potential predictive role for immunotherapies. Several studies have explored the clinical impact of immune therapies in the management of these histotypes leading to controversial results. The presence of Tumor Infiltrating Lymphocytes (TIL) seems to correlate with an improvement in the survival of patients and with a higher responsiveness to immunotherapy. In this context, it is important to consider that also immune-related genes (IRGs) have been demonstrated to have a key role in tumorigenesis and in the building of tumor immune microenvironment. The IRGs landscape in soft tissue and bone sarcomas is characterized by the connection between several tumor-related genes that can assume a potential prognostic and predictive therapeutic role. In this paper, we reviewed the state of art of the principal immune strategies in the management of sarcomas including their clinical and translational relevance.

• Publisher: Frontiers Media SA,Frontiers Media S.A
• Subject: Animals / Bone cancer / Cancer therapies / Chemotherapy / Cytotoxicity / Extracellular matrix / Genes / Genotype & phenotype / Humans / immune cells / immune-based classification / Immunology / Immunotherapy / Immunotherapy - methods / Liposarcoma / Lymphocytes / Lymphocytes, Tumor-Infiltrating - immunology / Lymphocytes, Tumor-Infiltrating - metabolism / Medical prognosis / Mesenchyme / Metastasis / Microenvironments / Mutation / Prognosis / Rhabdomyosarcoma / Sarcoma / Sarcoma - immunology / Sarcoma - therapy / Translation / Translational Research, Biomedical / Tumor cells / tumor immune microenvironment / tumor infiltrating lymphocytes / Tumor Microenvironment - immunology / tumor-related genes / Tumorigenesis / Tumors